These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25559827)

  • 41. Diagnosis and management of cardiac allograft vasculopathy.
    Ortega-Legaspi JM; Bravo PE
    Heart; 2022 Apr; 108(8):586-592. PubMed ID: 34340994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy.
    Nfor T; Ansaarie I; Gupta A; Bajwa T; Allaqaband S
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):543-9. PubMed ID: 19405161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac Allograft Vasculopathy: The Enduring Enemy of Cardiac Transplantation.
    Nikolova AP; Kobashigawa JA
    Transplantation; 2019 Jul; 103(7):1338-1348. PubMed ID: 31241553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Early diagnosis and management of cardiac allograft vasculopathy: is it time for a standardized approach?].
    Moschella MM; Turco A; Ferlini M; Ghio S; Pellegrini C; Cattadori B; Ferrario M; Pelenghi S; Visconti LO
    G Ital Cardiol (Rome); 2021 May; 22(5):377-385. PubMed ID: 33960981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo comparison between cardiac allograft vasculopathy and native atherosclerosis using near-infrared spectroscopy and intravascular ultrasound.
    Zheng B; Maehara A; Mintz GS; Nazif TM; Waksman Y; Qiu F; Jaquez L; Rabbani LE; Apfelbaum MA; Ali ZA; Dalton K; Xu K; Marboe CC; Mancini DM; Weisz G
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):985-91. PubMed ID: 25719180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early aspirin use and the development of cardiac allograft vasculopathy.
    Kim M; Bergmark BA; Zelniker TA; Mehra MR; Stewart GC; Page DS; Woodcome EL; Smallwood JA; Gabardi S; Givertz MM
    J Heart Lung Transplant; 2017 Dec; 36(12):1344-1349. PubMed ID: 28781013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection and imaging of cardiac allograft vasculopathy.
    Pollack A; Nazif T; Mancini D; Weisz G
    JACC Cardiovasc Imaging; 2013 May; 6(5):613-23. PubMed ID: 23680373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Uber PA; Ventura HO; Scott RL; Park MH
    J Am Coll Cardiol; 2004 Mar; 43(5):806-10. PubMed ID: 14998621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy.
    Cilingiroglu M; Chilakapati V; Dunlap S; Leesar MA
    Cardiovasc Revasc Med; 2010; 11(2):120-3. PubMed ID: 20347805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.
    Javaheri A; Saha N; Lilly SM
    Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy.
    Reddy PR; Gulati A; Steen L; Sinacore J; Leya F; Heroux A
    J Heart Lung Transplant; 2008 Nov; 27(11):1222-8. PubMed ID: 18971095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting the development of cardiac allograft vasculopathy.
    Seki A; Fishbein MC
    Cardiovasc Pathol; 2014; 23(5):253-60. PubMed ID: 24972526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study.
    Pighi M; Tomai F; Petrolini A; de Luca L; Tarantini G; Barioli A; Colombo P; Klugmann S; Ferlini M; Ormezzano MF; Loi B; Calabrò P; Bianchi RM; Faggian G; Forni A; Vassanelli C; Valgimigli M; Ribichini F
    J Cardiovasc Transl Res; 2016 Feb; 9(1):40-8. PubMed ID: 26684009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnosis, prevention and treatment of cardiac allograft vasculopathy].
    Calé R; Rebocho MJ; Aguiar C; Almeida M; Queiroz E Melo J; Silva JA
    Rev Port Cardiol; 2012 Nov; 31(11):721-30. PubMed ID: 22999223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical implications of intracoronary imaging in cardiac allograft vasculopathy.
    Guddeti RR; Matsuo Y; Matsuzawa Y; Aoki T; Lerman LO; Kushwaha SS; Lerman A
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25596140
    [No Abstract]   [Full Text] [Related]  

  • 60. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy.
    Floré V; Brown AJ; Pettit SJ; West NEJ; Lewis C; Parameshwar J; Hoole SP
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29194769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.